Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour.
about
Acute and fractionated irradiation differentially modulate glioma stem cell division kineticsThe hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy.Targeting hypoxic tumour cells to overcome metastasis.Use of perfluorochemical emulsions in cancer therapy.ICRF-159 enhancement of radiation response in combined modality therapies. I. Time/dose relationships for tumour response.Influence of tumour size on radiosensitization by misonidazole.The relationship between tissue oxygenation and redox status using magnetic resonance imaging.Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.Local failure patterns for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy.Tumor hypoxia: its impact on cancer therapy.Biological basis for the interaction of chemotherapeutic agents and radiation therapy.The effect of tumor size on F-18-labeled fluorodeoxyglucose and fluoroerythronitroimidazole uptake in a murine sarcoma model.Unified approach to growth and aging in biological, technical and biotechnical systems.Tumour size: a factor influencing the isoeffect analysis of tumour response to combined modalities.The HYP-RT hypoxic tumour radiotherapy algorithm and accelerated repopulation dose per fraction study.Cell cycle distribution of hypoxia and progression of hypoxic tumour cells in vivo.Whole-body hyperthermia as an adjuvant to treatment with platinum complexes with or without etanidazole in mice bearing the Lewis lung carcinoma or the FSaLL fibrosarcoma.Experience of weekly cisplatin concurrent with intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma patients with resistance to neoadjuvant chemotherapy.Regression curves of brain metastases after gamma knife irradiation: Difference by tumor and patient characteristics.
P2860
Q30537413-08D59588-6743-4E5C-9309-AEC448F984FEQ34005923-CDAA0552-7EAE-400C-B223-23BA29F269FDQ34086671-3C473B07-2F6D-46BA-9526-0E1D9B1AE031Q35361796-30757675-05B8-4BF6-96B8-F54BD87A3415Q36043008-C8B895A6-91EC-4A26-BBCF-3FC600315E73Q36290665-916DEF1B-FC35-4BF7-900B-060F8E5463F7Q36642980-6A34C13B-A2AC-4655-9730-5E6A385364F3Q37419513-26634F93-761E-4440-A889-435D8397D99AQ37702961-6609A491-C259-4903-9EE0-25FE924DD859Q39763935-BBCD3481-9D78-4AEC-B470-9A0745F464E3Q39816107-87BE8382-9ACA-439A-9688-663921411433Q40914431-0B081ECC-ABBA-4D3A-ACE5-02FAE603DDECQ42065954-E1052E17-59A7-406B-83BC-5B2DABA3AE28Q42067528-A94ECCCF-DC81-44BE-B9F7-557C2FB66537Q42218801-4DEA13F0-3343-4EAC-B878-09B2934E1227Q42860709-A00F9883-E4C7-4F71-99A9-FCF2442E4570Q46979930-48CDA7AA-DB15-45FD-BFDF-D2E3758BE35AQ47141804-EDAFC4EC-1B4E-4165-A3EF-EB455B916FAFQ48372113-1C860531-9C37-4CED-A201-E489A36C28AB
P2860
Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
Influence of tumour size on hy ...... sitivity of Lewis lung tumour.
@ast
Influence of tumour size on hy ...... sitivity of Lewis lung tumour.
@en
type
label
Influence of tumour size on hy ...... sitivity of Lewis lung tumour.
@ast
Influence of tumour size on hy ...... sitivity of Lewis lung tumour.
@en
prefLabel
Influence of tumour size on hy ...... sitivity of Lewis lung tumour.
@ast
Influence of tumour size on hy ...... sitivity of Lewis lung tumour.
@en
P2093
P2860
P356
P1476
Influence of tumour size on hy ...... sitivity of Lewis lung tumour.
@en
P2093
J A Stanley
W U Shipley
P2860
P2888
P304
P356
10.1038/BJC.1977.160
P407
P577
1977-07-01T00:00:00Z